Biography

Huiwen Zheng, Ph.D.
Associate Researcher, Master's Supervisor
Affiliation: Respiratory Diseases Research Laboratory, Beijing Children's Hospital, Capital Medical University

Research Focus:
Epidemiology, diagnostics, and drug resistance of Mycobacterium tuberculosis and nontuberculous mycobacteria (NTM).

Grants:
Principal Investigator of projects funded by:

Beijing Postdoctoral Research Foundation

Beijing Natural Science Foundation

Publications:
30 peer-reviewed articles (first/corresponding author), including 22 SCI-indexed papers.

Professional Service:

Committee Member, Basic Science Branch, Chinese Antituberculosis Association

Committee Member, School and Children's Branch, Chinese Antituberculosis Association

Expertise

TB Diagnostics
Public Health

Key Impacts

Innovo GenMax MTB-RIF/INH: A moderate-complexity automated NAAT for rapid simultaneous detection of M. tuberculosis complex and rifampin/isoniazid resistance

Innovo GenMax MTB-RIF/INH is a rapid and automated assay with high sensitivity for MTBC detection, suitable for decentralized settings. While its performance for RIF/INH resistance detection is competitive with existing assays, sensitivity gaps relative to WHO targets necessitate optimization.

Source: Conference 2024